Dr. Bravi has been CMO and VP Drug Development Lundbeck USA, Chief Scientific Officer at the Lundbeck Institute, Vice President, Clinical Development Centre Europe, Latin America, and Canada in the Drug Development Organization at Lundbeck Pharma in Copenhagen, Denmark. Daniele is a member of the R&D Executive Committee at Lundbeck. Dr. Bravi is an Italian citizen. His educational credentials include a Medical Degree from the “La Sapienza” University, Rome, Italy; and he is Board Certified in Neurology at the dept of Neuroscience, University of Rome. Dr. Bravi has been Author and Co-Author of several publications in the field of Neuroscience.
Dr. Daniele Bravi is present field of interest focuses on pharmacology and research of neurodegenerative disorders.